Cadila Healthcare strengthens on reporting 94% rise in Q2 consolidated net profit

31 Oct 2013 Evaluate

Cadila Healthcare is currently trading at Rs 665.00, up by 4.75 points or 0.72% from its previous closing of Rs. 660.25 on the BSE.

The scrip opened at Rs 662.00 and has touched a high and low of Rs 692.20 and Rs 656.95 respectively. So far 123282 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 5 has touched a 52 week high of Rs 924.60 on 22-Feb-2013 and a 52 week low of Rs 631.00 on 20-Aug-2013.

Last one week high and low of the scrip stood at Rs 669.00 and Rs 650.00 respectively. The current market cap of the company is Rs 13677.20 crore.

The promoters holding in the company stood at 74.79% while Institutions and Non-Institutions held 14.71% and 10.50% respectively.

Cadila Healthcare has reported results for the second quarter ended September 30, 2013.

The company has reported 81.57% rise in its net profit at Rs 151.76 crore for the quarter as compared to Rs 83.58 crore for the same quarter in the previous year. Total income of the company has increased by 10.72% at Rs 993.69 crore for quarter under review as compared to Rs  897.41 crore for the quarter ended September 30, 2012.

On the consolidated basis, the group has registered a growth of 93.75% in net profit after taxes, minority interest and share of profit / (loss) of associates  at Rs 183.37 crore as compared to Rs 94.64 crore in the same quarter previous year. Total income of the group rose 13.18% to Rs 1759.02 crore for quarter under review as against Rs 1554.10 crore in corresponding quarter previous year.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×